NewSquare Capital’s Boston Scientific BSX Stock Holding History

NewSquare Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-62,191	Closed	-$6.68M	–	331
2025 Q2	$6.68M	Buy	62,191 +2,341	+4%	+$237K	0.5%	65
2025 Q1	$6.04M	Buy	59,850 +59,755	+62,900%	+$6.02M	0.49%	65
2024 Q4	$8.48K	Buy	+95	New	+$8.36K	﹤0.01%	285
2024 Q1	–	Sell	-1,763	Closed	-$102K	–	453
2023 Q4	$102K	Sell	1,763 -58,892	-97%	-$3.14M	0.01%	166
2023 Q3	$3.2M	Buy	60,655 +5,210	+9%	+$273K	0.34%	88
2023 Q2	$3M	Buy	55,445 +640	+1%	+$33.4K	0.31%	97
2023 Q1	$2.74M	Buy	+54,805	New	+$2.58M	0.32%	100
2020 Q2	–	Sell	-770	Closed	-$25K	–	375
2020 Q1	$25K	Buy	+770	New	+$30.1K	﹤0.01%	201
2019 Q3	–	Sell	-770	Closed	-$33K	–	283
2019 Q2	$33K	Hold	770	–	–	0.01%	193
2019 Q1	$30K	Hold	770	–	–	0.01%	187
2018 Q4	$27K	Hold	770	–	–	0.01%	184
2018 Q3	$30K	Hold	770	–	–	0.01%	189
2018 Q2	$26K	Buy	+770	New	+$23.2K	0.01%	203

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NewSquare Capital's BSX Position: Q3 2025 in Review

NewSquare Capital sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 62,191 shares — an estimated $6.68M sold.

NewSquare Capital first reported a position in BSX in Q2 2018 and held it in 13 quarters. The position peaked at $6.68M in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

NewSquare Capital reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
NewSquare Capital sold 62,191 Boston Scientific shares in Q3 2025, an estimated $6.68M.
NewSquare Capital first reported a position in Boston Scientific in Q2 2018 and held it in 13 quarters.
NewSquare Capital's Boston Scientific position peaked at $6.68M in Q2 2025.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.